Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates.
SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis.
induces trained immunity in vitro.
Fucosylated N-glycans as early biomarkers of COVID-19 severity.
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial.
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses.
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective.
Actin-regulated Siglec-1 nanoclustering influences HIV-1 capture and virus-containing compartment formation in dendritic cells.
Highlights from the Tenth International Workshop on HIV Persistence during Therapy, December 13-16, 2022, Miami, Florida-USA.
Africa-specific human genetic variation near CHD1L associates with HIV-1 load.